Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 29;38(2):132-140.
doi: 10.1093/fampra/cmaa056.

Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study

Affiliations

Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study

Tomas Forslund et al. Fam Pract. .

Abstract

Background: Treatment of multimorbid patients can be improved. Development of patient-centred care of high-quality requires context-bound understanding of the multimorbid population's patterns of demographics, co-morbidities and medication use.

Objective: The aim of this study was to identify patterns of multimorbidity in the total population of Region Stockholm, Sweden, by exploring demographics, claimed prescription drugs, risk of mortality and non-random association of conditions.

Methods: In this cross-sectional descriptive population-based cohort study, we extracted data from the Swedish VAL database (N = 2 323 667) including all consultations in primary and specialized outpatient care, all inpatient care and all prescriptions claimed during 2017. We report number of chronic conditions and claimed prescription drugs, physical and mental co-morbidity, and 1-year mortality. We stratified the analyses by sex. We examined non-random associations between diseases using cluster analysis.

Results: In total, 21.6% had multimorbidity (two or more chronic conditions) and 24.1% had polypharmacy (more than five claimed prescription drugs). Number of claimed drugs, co-occurrence of mental and physical conditions, and 1-year mortality increased as multimorbidity increased. We identified seven multimorbidity clusters with clinically distinct characteristics. The smallest cluster (7% of individuals) had prominent cardiovascular disease, the highest 1-year mortality rate, high levels of multimorbidity and polypharmacy, and was much older. The largest cluster (27% of individuals) was younger and heterogenous, with primarily mental health problems.

Conclusions: Individuals with chronic conditions often show clinical complexity with both concordant and discordant conditions and polypharmacy. This study indicates that clinical guidelines addressing clustering of conditions may be one strategy for managing complexity.

Keywords: Chronic disease; frailty; multimorbidity; phamacology/drug reactions; population health; primary health care.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportion of the population in 2017 (N = 2 323 667) with (A) number of diagnoses per age group and (B) numbers of claimed prescription drugs per age group.

References

    1. Uijen AA, van de Lisdonk EH. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract 2008; 14 (suppl 1): 28–32. - PubMed
    1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380: 37–43. - PubMed
    1. Pefoyo AJ, Bronskill SE, Gruneir Aet al. . The increasing burden and complexity of multimorbidity. BMC Public Health 2015; 15: 415. - PMC - PubMed
    1. Violan C, Foguet-Boreu Q, Flores-Mateo Get al. . Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One 2014; 9: e102149. - PMC - PubMed
    1. Perkins AJ, Kroenke K, Unützer Jet al. . Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol 2004; 57: 1040–8. - PubMed

Publication types